SYNCOMF Syncom Formulation (India) Ltd. NSE · India

Syncom Formulation (India) (SYNCOMF) news

Syncom Formulation (India) Ltd. is a public biotech or pharmaceutical company listed on NSE under the ticker SYNCOMF, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Syncom Formulation (India) news

We have not published a story on Syncom Formulation (India) yet. When there is news, it will appear here.

Questions about Syncom Formulation (India)

What is the ticker symbol of Syncom Formulation (India)?

Syncom Formulation (India) Ltd. trades under the ticker SYNCOMF on NSE.

Where is Syncom Formulation (India) listed?

Syncom Formulation (India) Ltd. is listed on NSE. Our directory also records these other listings: BSE:SYNCOMF.

Which country or territory is Syncom Formulation (India) listed under?

Our directory records Syncom Formulation (India) Ltd. under India.

What does Syncom Formulation (India) do?

Our directory classifies Syncom Formulation (India) Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Syncom Formulation (India)?

The ISIN recorded for Syncom Formulation (India) Ltd. is INE312C01025.

Does aibio.space cover Syncom Formulation (India)?

aibio.space lists Syncom Formulation (India) Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Syncom Formulation (India)?

Companies in our directory listed in the same country and business area as Syncom Formulation (India): Gujarat Themis Biosyn, Smruthi Organics, Infinium Pharmachem, Indegene, Gufic Biosciences, Sanjivani Paranteral.

Investor discussion: Syncom Formulation (India)

Members talk about Syncom Formulation (India) (SYNCOMF). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:SYNCOMF on TradingView.

Listing details

Company: Syncom Formulation (India) Ltd.
Ticker: SYNCOMF
Listing: NSE
Country or territory: India
Business scope: Pharmaceuticals: Major
ISIN: INE312C01025
Other listed symbols: BSE:SYNCOMF
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction